The Oncology Drugs Market exhibits distinct regional dynamics, with innovation, consumption, and regulatory environments varying significantly across key geographic regions. The market is disproportionately influenced by R&D activities and clinical trial concentration in developed markets, which typically feature advanced healthcare infrastructure, higher spending power, and sophisticated...